Directory UMM :Data Elmu:jurnal:A:Atherosclerosis:Vol152.Issue1.Sep2000:
Atherosclerosis 151 (2000) 601 – 603
www.elsevier.com/locate/atherosclerosis
Author index
Volume 151 (2000)
Ahotupa, M., see Vasankari, T. 151, 399
Aizieniène, L., see Kristenson, M. 151, 501
Andersson, A., B. Hultberg, A. Lindgren, Redox status of plasma
homocysteine and other plasma thiols in stroke patients 151, 535
Arnett, D.K., see Tsai, M.Y. 151, 519
Arosio, M., G. Sartore, C.M. Rossi, G. Casati, G. Faglia, E. Manzato,
LDL physical properties, lipoprotein and Lp(a) levels in acromegalic
patients. Effects of octreotide therapy 151, 551
Auwerx, J., see Pihlajamäki, J. 151, 567
Avella, M.A., see Grieve, D.J. 151, 471
Bäckström, A.-C., see Karjalainen, A. 151, 559
Baldassarre, D., F. Veglia, C. Gobbi, G. Gallus, A. Ventura, G.
Crepaldi, M. Fisicaro, S. Rimondi, G. Ricci, M. Mancini, M.G.
Bond, S. Collatina, C.R. Sirtori, Intima-media thickness after
pravastatin stabilizes also in patients with moderate to no reduction
in LDL-cholesterol levels: the carotid atherosclerosis Italian
ultrasound study 151, 575
Banyai, S., see Schmaldienst, S. 151, 493
Barnard, J.R., see Sun, Z. 151, 381
Belgore, F.M., G.Y.H. Lip, A.D. Blann, Successful therapy reduces
levels of vascular endothelial growth factor (VEGF) in patients with
hypertension and patients with hypercholesterolemia 151, 599
Benson, G.M., see Grimsditch, D.C. 151, 389
Bergdahl, B., see Kristenson, M. 151, 501
Beyzade, S., see Dunleavey, L. 151, 587
Blann, A.D., see Belgore, F.M. 151, 599
Bobik, A., see Ward, M.R. 151, 407
Bond, M.G., see Baldassarre, D. 151, 575
Botham, K.M., see Grieve, D.J. 151, 471
Bo, Z., see Kristenson, M. 151, 501
Brattström, L., see Nielsen, N.E. 151, 423
Bredie, S.J.H., see Hoffer, M.J.V. 151, 443
Casati, G., see Arosio, M. 151, 551
Collatina, S., see Baldassarre, D. 151, 575
Crepaldi, G., see Baldassarre, D. 151, 575
Deeb, S., see Pihlajamäki, J. 151, 567
Demacker, P.N.M., see Hoffer, M.J.V. 151, 443
Derfler, K., see Schmaldienst, S. 151, 493
Dunleavey, L., S. Beyzade, S. Ye, Rapid genotype analysis of the
stromelysin gene 5A/6A polymorphism 151, 587
Eckardstein, A., see Eue, I. 151, 593
Eckfeldt, J.H., see Tsai, M.Y. 151, 519
Ehnholm, C., see Huuskonen, J. 151, 451
Ekström, M., see Huuskonen, J. 151, 451
Elliott, J., see Grieve, D.J. 151, 471
Ellison, R.C., see Tsai, M.Y. 151, 519
Eue, I., C. Langer, A. Eckardstein, C. Sorg, Myeloid related protein
PII: S0021-9150(00)00542-6
(MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of
ApoE null mice 151, 593
Faglia, G., see Arosio, M. 151, 551
Ferns, G.A.A., see Williams, J.C. 151, 463
Fisicaro, M., see Baldassarre, D. 151, 575
Forster, L.A., see Williams, J.C. 151, 463
Fotherby, M.D., see Williams, J.C. 151, 463
Frants, R.R., see Hoffer, M.J.V. 151, 443
Friedlander, Y., see Kark, J.D. 151, 509
Gallus, G., see Baldassarre, D. 151, 575
Gobbi, C., see Baldassarre, D. 151, 575
Goto, Y., see Kojima, S. 151, 585
Grieve, D.J., M.A. Avella, K.M. Botham, J. Elliott, Chylomicron
remnants potentiate phenylephrine-induced contractions of rat aorta
by an endothelium-dependent mechanism 151, 471
Grimsditch, D.C., S. Penfold, J. Latcham, M. Vidgeon-Hart, P.H.E.
Groot, G.M. Benson, C3H apoE( −/ −) mice have less
atherosclerosis than C57BL apoE( −/ − ) mice despite having a more
atherogenic serum lipid profile 151, 389
Groot, P.H.E., see Grimsditch, D.C. 151, 389
Gylling, H., see Lindbohm, N. 151, 545
Heikkinen, J., see Karjalainen, A. 151, 559
Heinonen, O., see Vasankari, T. 151, 399
Heinz, G., see Schmaldienst, S. 151, 493
Hoffer, M.J.V., H. Snieder, S.J.H. Bredie, P.N.M. Demacker, J.J.P.
Kastelein, R.R. Frants, A.F.H. Stalenhoef, The V73M mutation in
the hepatic lipase gene is associated with elevated cholesterol levels
in
four
Dutch
pedigrees
with
familial
combined
hyperlipidemia 151, 443
Horie, H., see Kojima, S. 151, 585
Hörl, W.H., see Schmaldienst, S. 151, 493
Hsieh,
C.-C.,
M.-H.
Yen,
H.-W.
Liu,
Y.-T.
Lau,
Lysophosphatidylcholine induces apoptotic and non-apoptotic
death in vascular smooth muscle cells: in comparison with oxidized
LDL 151, 481
Hultberg, B., see Andersson, A. 151, 535
Hultberg, B., see Nielsen, N.E. 151, 423
Huuskonen, J., M. Ekström, E. Tahvanainen, A. Vainio, J. Metso, P.
Pussinen, C. Ehnholm, V.M. Olkkonen, M. Jauhiainen,
Quantification of human plasma phospholipid transfer protein
(PLTP): relationship between PLTP mass and phospholipid transfer
activity 151, 451
Irjala, K., see Vasankari, T. 151, 399
Ishizaki, M., P. Martikainen, H. Nakagawa, M. Marmot, The
relationship between employment grade and plasma fibrinogen level
among Japanese male employees 151, 415
Iwai, N., see Kojima, S. 151, 585
602
Author index 6ol. 151 (2000)
Jacques, P.F., see Jenner, J.L. 151, 541
Jansen, M., see Schmaldienst, S. 151, 493
Jauhiainen, M., see Huuskonen, J. 151, 451
Jenner, J.L., P.F. Jacques, L.J. Seman, E.J. Schaefer, Ascorbic acid
supplementation does not lower plasma lipoprotein(a)
concentrations 151, 541
Jennings, G.L., see Ward, M.R. 151, 407
density lipoprotein receptor gene in a German patient with
homozygous familial hypercholesterolemia 151, 525
Nielsen, N.E., L. Brattström, B. Hultberg, F. Landgren, E. Swahn,
Plasma total homocysteine levels in postmenopausal women with
unstable coronary artery disease 151, 423
Nissen, H., see Nauck, M.S. 151, 525
Nonogi, H., see Kojima, S. 151, 585
Kanellakis, P., see Ward, M.R. 151, 407
Karjalainen, A., J. Heikkinen, M.J. Savolainen, A.-C. Bäckström,
Y.A. Kesäniemi, Regulation of plasma low density lipoprotein
levels in postmenopausal women 151, 559
Karjalainen, L., see Pihlajamäki, J. 151, 567
Kark, J.D., R. Sinnreich, E. Leitersdorf, Y. Friedlander, S. Shpitzen,
G. Luc, Taq1B CETP polymorphism, plasma CETP, lipoproteins,
apolipoproteins and sex differences in a Jewish population sample
characterized by low HDL-cholesterol 151, 509
Kastelein, J.J.P., see Hoffer, M.J.V. 151, 443
Kesäniemi, Y.A., see Karjalainen, A. 151, 559
Kinoshita, M., see Kojima, S. 151, 585
Kojima, S., Y. Goto, H. Nonogi, H. Horie, M. Kinoshita, N. Iwai,
Role of a p53 polymorphism in luminal narrowing after balloon
coronary angioplasty 151, 585
Kristenson, M., C. Lassvik, B. Bergdahl, Z. Kucinskiène, L.
Aizieniène, Z. Bo, L. Schäfer Elinder, A.G. Olsson, Ultrasound
determined carotid and femoral atherosclerosis in Lithuanian and
Swedish men: the LiVicordia study 151, 501
Kucinskiène, Z., see Kristenson, M. 151, 501
Kuusisto, J., see Pihlajamäki, J. 151, 567
Olkkonen, V.M., see Huuskonen, J. 151, 451
Olsson, A.G., see Kristenson, M. 151, 501
Ordovas, J.M., see Sun, Z. 151, 381
Otto, C., P. Schwandt, More on atorvastatin and fibrinogen
Laakso, M., see Pihlajamäki, J. 151, 567
Landgren, F., see Nielsen, N.E. 151, 423
Langer, C., see Eue, I. 151, 593
Larson, I.A., see Sun, Z. 151, 381
Lassvik, C., see Kristenson, M. 151, 501
Latcham, J., see Grimsditch, D.C. 151, 389
Lau, Y.-T., see Hsieh, C.-C. 151, 481
Lehtonen-Veromaa, M., see Vasankari, T. 151, 399
Leino, A., see Vasankari, T. 151, 399
Leitersdorf, E., see Kark, J.D. 151, 509
Lindbohm, N., H. Gylling, T.E. Miettinen, T.A. Miettinen, Statin
treatment increases the sialic acid content of LDL in
hypercholesterolemic patients 151, 545
Lindgren, A., see Andersson, A. 151, 535
Lip, G.Y.H., see Belgore, F.M. 151, 599
Liu, H.-W., see Hsieh, C.-C. 151, 481
Luc, G., see Kark, J.D. 151, 509
Mancini, M., see Baldassarre, D. 151, 575
Manzato, E., see Arosio, M. 151, 551
Marklund, S.L., see Strålin, P. 151, 433
Marmot, M., see Ishizaki, M. 151, 415
Martikainen, P., see Ishizaki, M. 151, 415
März, W., see Nauck, M.S. 151, 525
Mattern, D., see Nauck, M.S. 151, 525
Metso, J., see Huuskonen, J. 151, 451
Miettinen, R., see Pihlajamäki, J. 151, 567
Miettinen, T.A., see Lindbohm, N. 151, 545
Miettinen, T.E., see Lindbohm, N. 151, 545
Möttönen, T., see Vasankari, T. 151, 399
Mykkänen, L., see Pihlajamäki, J. 151, 567
Nakagawa, H., see Ishizaki, M. 151, 415
Nauck, M.A., see Nauck, M.S. 151, 525
Nauck, M.S., H. Scharnagl, H. Nissen, C. Schürmann, D. Mattern,
M.A. Nauck, H. Wieland, W. März, FH-Freiburg: a novel
missense mutation (C317Y) in growth factor repeat A of the low
151, 591
Penfold, S., see Grimsditch, D.C. 151, 389
Pihlajamäki, J., R. Miettinen, R. Valve, L. Karjalainen, L. Mykkänen,
J. Kuusisto, S. Deeb, J. Auwerx, M. Laakso, The Pro12Ala
substitution in the peroxisome proliferator activated receptor
gamma 2 is associated with an insulin-sensitive phenotype in families
with familial combined hyperlipidemia and in nondiabetic elderly
subjects with dyslipidemia 151, 567
Pussinen, P., see Huuskonen, J. 151, 451
Ramsey, D., see Ward, M.R. 151, 407
Ricci, G., see Baldassarre, D. 151, 575
Rimondi, S., see Baldassarre, D. 151, 575
Ros, E., Intestinal absorption of triglyceride and cholesterol. Dietary
and pharmacological inhibition to reduce cardiovascular risk 151,
357
Rossi, C.M., see Arosio, M. 151, 551
Sartore, G., see Arosio, M. 151, 551
Savolainen, M.J., see Karjalainen, A. 151, 559
Schaefer, E.J., see Jenner, J.L. 151, 541
Schaefer, E.J., see Sun, Z. 151, 381
Schäfer Elinder, L., see Kristenson, M. 151, 501
Scharnagl, H., see Nauck, M.S. 151, 525
Schmaldienst, S., S. Banyai, T.M. Stulnig, G. Heinz, M. Jansen, W.H.
Hörl, K. Derfler, Prospective randomised cross-over comparison
of three LDL-apheresis systems in statin pretreated patients with
familial hypercholesterolaemia 151, 493
Schürmann, C., see Nauck, M.S. 151, 525
Schwandt, P., see Otto, C. 151, 591
Seman, L.J., see Jenner, J.L. 151, 541
Shpitzen, S., see Kark, J.D. 151, 509
Sinnreich, R., see Kark, J.D. 151, 509
Sirtori, C.R., see Baldassarre, D. 151, 575
Snieder, H., see Hoffer, M.J.V. 151, 443
Sorg, C., see Eue, I. 151, 593
Stalenhoef, A.F.H., see Hoffer, M.J.V. 151, 443
Strålin, P., S.L. Marklund, Multiple cytokines regulate the expression
of extracellular superoxide dismutase in human vascular smooth
muscle cells 151, 433
Stulnig, T.M., see Schmaldienst, S. 151, 493
Sun, Z., I.A. Larson, J.M. Ordovas, J.R. Barnard, E.J. Schaefer, Effects
of age, gender, and lifestyle factors on plasma apolipoprotein A-IV
concentrations 151, 381
Swahn, E., see Nielsen, N.E. 151, 423
Tahvanainen, E., see Huuskonen, J. 151, 451
Tsai, M.Y., D.K. Arnett, J.H. Eckfeldt, R.R. Williams, R.C. Ellison,
Plasma homocysteine and its association with carotid intimal-medial
wall thickness and prevalent coronary heart disease: NHLBI Family
Heart Study 151, 519
Tull, S.P., see Williams, J.C. 151, 463
Vainio, A., see Huuskonen, J. 151, 451
Valve, R., see Pihlajamäki, J. 151, 567
Author index 6ol. 151 (2000)
Vasankari, T., M. Lehtonen-Veromaa, T. Möttönen, M.
Ahotupa, K. Irjala, O. Heinonen, A. Leino, J. Viikari,
Reduced mildly oxidized LDL in young female athletes
399
Veglia, F., see Baldassarre, D. 151, 575
Ventura, A., see Baldassarre, D. 151, 575
Vidgeon-Hart, M., see Grimsditch, D.C. 151, 389
Viikari, J., see Vasankari, T. 151, 399
151,
Ward, M.R., P. Kanellakis, D. Ramsey, G.L. Jennings, A. Bobik,
603
Response to balloon injury is vascular bed specific: A
consequence of de novo vessel structure? 151, 407
Wieland, H., see Nauck, M.S. 151, 525
Williams, J.C., M.D. Fotherby, L.A. Forster, S.P. Tull, G.A.A.
Ferns, Mononuclear cell adhesion to collagen ex vivo is related
to pulse pressure in elderly subjects 151, 463
Williams, R.R., see Tsai, M.Y. 151, 519
Yen, M.-H., see Hsieh, C.-C. 151, 481
Ye, S., see Dunleavey, L. 151, 587
www.elsevier.com/locate/atherosclerosis
Author index
Volume 151 (2000)
Ahotupa, M., see Vasankari, T. 151, 399
Aizieniène, L., see Kristenson, M. 151, 501
Andersson, A., B. Hultberg, A. Lindgren, Redox status of plasma
homocysteine and other plasma thiols in stroke patients 151, 535
Arnett, D.K., see Tsai, M.Y. 151, 519
Arosio, M., G. Sartore, C.M. Rossi, G. Casati, G. Faglia, E. Manzato,
LDL physical properties, lipoprotein and Lp(a) levels in acromegalic
patients. Effects of octreotide therapy 151, 551
Auwerx, J., see Pihlajamäki, J. 151, 567
Avella, M.A., see Grieve, D.J. 151, 471
Bäckström, A.-C., see Karjalainen, A. 151, 559
Baldassarre, D., F. Veglia, C. Gobbi, G. Gallus, A. Ventura, G.
Crepaldi, M. Fisicaro, S. Rimondi, G. Ricci, M. Mancini, M.G.
Bond, S. Collatina, C.R. Sirtori, Intima-media thickness after
pravastatin stabilizes also in patients with moderate to no reduction
in LDL-cholesterol levels: the carotid atherosclerosis Italian
ultrasound study 151, 575
Banyai, S., see Schmaldienst, S. 151, 493
Barnard, J.R., see Sun, Z. 151, 381
Belgore, F.M., G.Y.H. Lip, A.D. Blann, Successful therapy reduces
levels of vascular endothelial growth factor (VEGF) in patients with
hypertension and patients with hypercholesterolemia 151, 599
Benson, G.M., see Grimsditch, D.C. 151, 389
Bergdahl, B., see Kristenson, M. 151, 501
Beyzade, S., see Dunleavey, L. 151, 587
Blann, A.D., see Belgore, F.M. 151, 599
Bobik, A., see Ward, M.R. 151, 407
Bond, M.G., see Baldassarre, D. 151, 575
Botham, K.M., see Grieve, D.J. 151, 471
Bo, Z., see Kristenson, M. 151, 501
Brattström, L., see Nielsen, N.E. 151, 423
Bredie, S.J.H., see Hoffer, M.J.V. 151, 443
Casati, G., see Arosio, M. 151, 551
Collatina, S., see Baldassarre, D. 151, 575
Crepaldi, G., see Baldassarre, D. 151, 575
Deeb, S., see Pihlajamäki, J. 151, 567
Demacker, P.N.M., see Hoffer, M.J.V. 151, 443
Derfler, K., see Schmaldienst, S. 151, 493
Dunleavey, L., S. Beyzade, S. Ye, Rapid genotype analysis of the
stromelysin gene 5A/6A polymorphism 151, 587
Eckardstein, A., see Eue, I. 151, 593
Eckfeldt, J.H., see Tsai, M.Y. 151, 519
Ehnholm, C., see Huuskonen, J. 151, 451
Ekström, M., see Huuskonen, J. 151, 451
Elliott, J., see Grieve, D.J. 151, 471
Ellison, R.C., see Tsai, M.Y. 151, 519
Eue, I., C. Langer, A. Eckardstein, C. Sorg, Myeloid related protein
PII: S0021-9150(00)00542-6
(MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of
ApoE null mice 151, 593
Faglia, G., see Arosio, M. 151, 551
Ferns, G.A.A., see Williams, J.C. 151, 463
Fisicaro, M., see Baldassarre, D. 151, 575
Forster, L.A., see Williams, J.C. 151, 463
Fotherby, M.D., see Williams, J.C. 151, 463
Frants, R.R., see Hoffer, M.J.V. 151, 443
Friedlander, Y., see Kark, J.D. 151, 509
Gallus, G., see Baldassarre, D. 151, 575
Gobbi, C., see Baldassarre, D. 151, 575
Goto, Y., see Kojima, S. 151, 585
Grieve, D.J., M.A. Avella, K.M. Botham, J. Elliott, Chylomicron
remnants potentiate phenylephrine-induced contractions of rat aorta
by an endothelium-dependent mechanism 151, 471
Grimsditch, D.C., S. Penfold, J. Latcham, M. Vidgeon-Hart, P.H.E.
Groot, G.M. Benson, C3H apoE( −/ −) mice have less
atherosclerosis than C57BL apoE( −/ − ) mice despite having a more
atherogenic serum lipid profile 151, 389
Groot, P.H.E., see Grimsditch, D.C. 151, 389
Gylling, H., see Lindbohm, N. 151, 545
Heikkinen, J., see Karjalainen, A. 151, 559
Heinonen, O., see Vasankari, T. 151, 399
Heinz, G., see Schmaldienst, S. 151, 493
Hoffer, M.J.V., H. Snieder, S.J.H. Bredie, P.N.M. Demacker, J.J.P.
Kastelein, R.R. Frants, A.F.H. Stalenhoef, The V73M mutation in
the hepatic lipase gene is associated with elevated cholesterol levels
in
four
Dutch
pedigrees
with
familial
combined
hyperlipidemia 151, 443
Horie, H., see Kojima, S. 151, 585
Hörl, W.H., see Schmaldienst, S. 151, 493
Hsieh,
C.-C.,
M.-H.
Yen,
H.-W.
Liu,
Y.-T.
Lau,
Lysophosphatidylcholine induces apoptotic and non-apoptotic
death in vascular smooth muscle cells: in comparison with oxidized
LDL 151, 481
Hultberg, B., see Andersson, A. 151, 535
Hultberg, B., see Nielsen, N.E. 151, 423
Huuskonen, J., M. Ekström, E. Tahvanainen, A. Vainio, J. Metso, P.
Pussinen, C. Ehnholm, V.M. Olkkonen, M. Jauhiainen,
Quantification of human plasma phospholipid transfer protein
(PLTP): relationship between PLTP mass and phospholipid transfer
activity 151, 451
Irjala, K., see Vasankari, T. 151, 399
Ishizaki, M., P. Martikainen, H. Nakagawa, M. Marmot, The
relationship between employment grade and plasma fibrinogen level
among Japanese male employees 151, 415
Iwai, N., see Kojima, S. 151, 585
602
Author index 6ol. 151 (2000)
Jacques, P.F., see Jenner, J.L. 151, 541
Jansen, M., see Schmaldienst, S. 151, 493
Jauhiainen, M., see Huuskonen, J. 151, 451
Jenner, J.L., P.F. Jacques, L.J. Seman, E.J. Schaefer, Ascorbic acid
supplementation does not lower plasma lipoprotein(a)
concentrations 151, 541
Jennings, G.L., see Ward, M.R. 151, 407
density lipoprotein receptor gene in a German patient with
homozygous familial hypercholesterolemia 151, 525
Nielsen, N.E., L. Brattström, B. Hultberg, F. Landgren, E. Swahn,
Plasma total homocysteine levels in postmenopausal women with
unstable coronary artery disease 151, 423
Nissen, H., see Nauck, M.S. 151, 525
Nonogi, H., see Kojima, S. 151, 585
Kanellakis, P., see Ward, M.R. 151, 407
Karjalainen, A., J. Heikkinen, M.J. Savolainen, A.-C. Bäckström,
Y.A. Kesäniemi, Regulation of plasma low density lipoprotein
levels in postmenopausal women 151, 559
Karjalainen, L., see Pihlajamäki, J. 151, 567
Kark, J.D., R. Sinnreich, E. Leitersdorf, Y. Friedlander, S. Shpitzen,
G. Luc, Taq1B CETP polymorphism, plasma CETP, lipoproteins,
apolipoproteins and sex differences in a Jewish population sample
characterized by low HDL-cholesterol 151, 509
Kastelein, J.J.P., see Hoffer, M.J.V. 151, 443
Kesäniemi, Y.A., see Karjalainen, A. 151, 559
Kinoshita, M., see Kojima, S. 151, 585
Kojima, S., Y. Goto, H. Nonogi, H. Horie, M. Kinoshita, N. Iwai,
Role of a p53 polymorphism in luminal narrowing after balloon
coronary angioplasty 151, 585
Kristenson, M., C. Lassvik, B. Bergdahl, Z. Kucinskiène, L.
Aizieniène, Z. Bo, L. Schäfer Elinder, A.G. Olsson, Ultrasound
determined carotid and femoral atherosclerosis in Lithuanian and
Swedish men: the LiVicordia study 151, 501
Kucinskiène, Z., see Kristenson, M. 151, 501
Kuusisto, J., see Pihlajamäki, J. 151, 567
Olkkonen, V.M., see Huuskonen, J. 151, 451
Olsson, A.G., see Kristenson, M. 151, 501
Ordovas, J.M., see Sun, Z. 151, 381
Otto, C., P. Schwandt, More on atorvastatin and fibrinogen
Laakso, M., see Pihlajamäki, J. 151, 567
Landgren, F., see Nielsen, N.E. 151, 423
Langer, C., see Eue, I. 151, 593
Larson, I.A., see Sun, Z. 151, 381
Lassvik, C., see Kristenson, M. 151, 501
Latcham, J., see Grimsditch, D.C. 151, 389
Lau, Y.-T., see Hsieh, C.-C. 151, 481
Lehtonen-Veromaa, M., see Vasankari, T. 151, 399
Leino, A., see Vasankari, T. 151, 399
Leitersdorf, E., see Kark, J.D. 151, 509
Lindbohm, N., H. Gylling, T.E. Miettinen, T.A. Miettinen, Statin
treatment increases the sialic acid content of LDL in
hypercholesterolemic patients 151, 545
Lindgren, A., see Andersson, A. 151, 535
Lip, G.Y.H., see Belgore, F.M. 151, 599
Liu, H.-W., see Hsieh, C.-C. 151, 481
Luc, G., see Kark, J.D. 151, 509
Mancini, M., see Baldassarre, D. 151, 575
Manzato, E., see Arosio, M. 151, 551
Marklund, S.L., see Strålin, P. 151, 433
Marmot, M., see Ishizaki, M. 151, 415
Martikainen, P., see Ishizaki, M. 151, 415
März, W., see Nauck, M.S. 151, 525
Mattern, D., see Nauck, M.S. 151, 525
Metso, J., see Huuskonen, J. 151, 451
Miettinen, R., see Pihlajamäki, J. 151, 567
Miettinen, T.A., see Lindbohm, N. 151, 545
Miettinen, T.E., see Lindbohm, N. 151, 545
Möttönen, T., see Vasankari, T. 151, 399
Mykkänen, L., see Pihlajamäki, J. 151, 567
Nakagawa, H., see Ishizaki, M. 151, 415
Nauck, M.A., see Nauck, M.S. 151, 525
Nauck, M.S., H. Scharnagl, H. Nissen, C. Schürmann, D. Mattern,
M.A. Nauck, H. Wieland, W. März, FH-Freiburg: a novel
missense mutation (C317Y) in growth factor repeat A of the low
151, 591
Penfold, S., see Grimsditch, D.C. 151, 389
Pihlajamäki, J., R. Miettinen, R. Valve, L. Karjalainen, L. Mykkänen,
J. Kuusisto, S. Deeb, J. Auwerx, M. Laakso, The Pro12Ala
substitution in the peroxisome proliferator activated receptor
gamma 2 is associated with an insulin-sensitive phenotype in families
with familial combined hyperlipidemia and in nondiabetic elderly
subjects with dyslipidemia 151, 567
Pussinen, P., see Huuskonen, J. 151, 451
Ramsey, D., see Ward, M.R. 151, 407
Ricci, G., see Baldassarre, D. 151, 575
Rimondi, S., see Baldassarre, D. 151, 575
Ros, E., Intestinal absorption of triglyceride and cholesterol. Dietary
and pharmacological inhibition to reduce cardiovascular risk 151,
357
Rossi, C.M., see Arosio, M. 151, 551
Sartore, G., see Arosio, M. 151, 551
Savolainen, M.J., see Karjalainen, A. 151, 559
Schaefer, E.J., see Jenner, J.L. 151, 541
Schaefer, E.J., see Sun, Z. 151, 381
Schäfer Elinder, L., see Kristenson, M. 151, 501
Scharnagl, H., see Nauck, M.S. 151, 525
Schmaldienst, S., S. Banyai, T.M. Stulnig, G. Heinz, M. Jansen, W.H.
Hörl, K. Derfler, Prospective randomised cross-over comparison
of three LDL-apheresis systems in statin pretreated patients with
familial hypercholesterolaemia 151, 493
Schürmann, C., see Nauck, M.S. 151, 525
Schwandt, P., see Otto, C. 151, 591
Seman, L.J., see Jenner, J.L. 151, 541
Shpitzen, S., see Kark, J.D. 151, 509
Sinnreich, R., see Kark, J.D. 151, 509
Sirtori, C.R., see Baldassarre, D. 151, 575
Snieder, H., see Hoffer, M.J.V. 151, 443
Sorg, C., see Eue, I. 151, 593
Stalenhoef, A.F.H., see Hoffer, M.J.V. 151, 443
Strålin, P., S.L. Marklund, Multiple cytokines regulate the expression
of extracellular superoxide dismutase in human vascular smooth
muscle cells 151, 433
Stulnig, T.M., see Schmaldienst, S. 151, 493
Sun, Z., I.A. Larson, J.M. Ordovas, J.R. Barnard, E.J. Schaefer, Effects
of age, gender, and lifestyle factors on plasma apolipoprotein A-IV
concentrations 151, 381
Swahn, E., see Nielsen, N.E. 151, 423
Tahvanainen, E., see Huuskonen, J. 151, 451
Tsai, M.Y., D.K. Arnett, J.H. Eckfeldt, R.R. Williams, R.C. Ellison,
Plasma homocysteine and its association with carotid intimal-medial
wall thickness and prevalent coronary heart disease: NHLBI Family
Heart Study 151, 519
Tull, S.P., see Williams, J.C. 151, 463
Vainio, A., see Huuskonen, J. 151, 451
Valve, R., see Pihlajamäki, J. 151, 567
Author index 6ol. 151 (2000)
Vasankari, T., M. Lehtonen-Veromaa, T. Möttönen, M.
Ahotupa, K. Irjala, O. Heinonen, A. Leino, J. Viikari,
Reduced mildly oxidized LDL in young female athletes
399
Veglia, F., see Baldassarre, D. 151, 575
Ventura, A., see Baldassarre, D. 151, 575
Vidgeon-Hart, M., see Grimsditch, D.C. 151, 389
Viikari, J., see Vasankari, T. 151, 399
151,
Ward, M.R., P. Kanellakis, D. Ramsey, G.L. Jennings, A. Bobik,
603
Response to balloon injury is vascular bed specific: A
consequence of de novo vessel structure? 151, 407
Wieland, H., see Nauck, M.S. 151, 525
Williams, J.C., M.D. Fotherby, L.A. Forster, S.P. Tull, G.A.A.
Ferns, Mononuclear cell adhesion to collagen ex vivo is related
to pulse pressure in elderly subjects 151, 463
Williams, R.R., see Tsai, M.Y. 151, 519
Yen, M.-H., see Hsieh, C.-C. 151, 481
Ye, S., see Dunleavey, L. 151, 587